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 Alcohol dehydrogenases 1.1
Alcohol dehydrogenases (ADH) are a group of enzyme catalyzing the  oxidation of 
alcohols to aldehydes and the reduction of aldehydes to alcohol by using nicotinamide 
adenine dinucleotide phosphate NAD(P)(H) as coenzyme [1]. Based on the length of 
primary sequence, they are classified into short-chain (SDR), medium-chain (MDR) and 
long-chain (LDR) dehydrogenase/reductases [2-5]. Through genome sequencing projects 
it is now clear that distinct families of ADH encode a large group of gene products within 
nearly every genome [6, 7]. This wide representation of oxidoreductases highlights their 
importance and functional diversity in the physiology of organisms reaching from 
prokaryotes to mammals [6]. ADHs from drosophilid species (DADHs) are typical 
members of the SDR family. 
 Functions of short-chain dehydrogenases/reductases 1.2
SDRs form a large and evolutionary old family of enzymes, and currently more 
than 47000 members, including species variants are known [8]. SDR members catalyze 
diverse biochemical reactions such as isomerization, epimerization and oxidoreduction 
[9]. SDRs are involved in hormone metabolism (retinol dehydrogenases, prostaglandin 
dehydrogenases, hydroxysteroid dehydrogenases, testosterone 5α-reductases) fatty acid 
oxidation (hydroxyacyl CoA dehydrogenases) or biotransformation of xenobiotics 
(carbonyl reductases, quinone reductases) [10-13]. Interestingly, hydroxysteroid 
dehydrogenases (HSDs) of the SDR super-family are implicated in polycystic kidney 
diseases [14], regulation of blood pressure [15], Alzheimer’s disease [16], obesity [17] 
and in the development of steroid dependent cancer forms [15]. The SDR superfamily 
therefore contains several important pharmaceutical targets. SDR family members 
including ADH from Drosophila melanogaster (DmADH) and Scaptodrosophila 
lebanonensis (SlADH) (formerly Drosophila lebanonensis) utilize nicotinamide adenine 
dinucleotides NAD(P)(H) as cofactors in the reduction or oxidation reactions. Currently 
there are around 300 x-ray crystal structures of SDRs  in the protein data bank 




Table 1. SlADHs structures available in the protein databank (www.pdb.org). 
PDB ID Ligand(s) Resolution Released Date Number of amino acids  Reference  
1A4U - 1,92 16.02.1999 508  [19] 
1B14 NAD+ 2,4 26.11.1999 508  [20] 
1B15 NAD-acetone 2,2 26.11.1999 508   [20]  
1B16 NAD-3-Pentanone 1,4 29.11.1999 508  [20] 
1B2L NAD-Cyclohexanone 1,6 26.11.1999 254  [20] 
1SBY NAD+ and 2,2,2-trifluoroethanol 1,1 22.02.2005 508 [21] 
1MG5 NADH and acetate 1,6 21.01.2005 510 [22] 
3RJ5 NAD+ 1,45 02.05.2012 508 [23] 
3RJ9 NAD+ 1,98 02.05.2012 1524 [23] 
 
 Reaction mechanism of DADH 1.3
Most of the SDR family members show a one-domain architecture with the 
substrate binding site located in the highly variable C-terminal region and a characteristic 
NAD(H)-binding motif or Rossmann fold in the N-terminal region. The overall structure 
of this monomer is folded into a central 8-stranded β-sheet and flanked on each side by 
three α-helices (Figure 1) [9, 19, 20, 22, 24, 25]. Among these enzymes,  conserved 
sequence regions include the cofactor binding Gly-X3-Gly-X-Gly motif in the N-terminal 
part, and an active site conformation nearly superimposable to each other with the 
catalytic important triad (Tyr, Lys, Ser) of amino acids [9, 26, 27]. Mutagenesis studies 





Figure 1: Skin mesh representation of substrate binding site (green) and the ‘Rossmann-fold’ (yellow) of 
SlADH in complex with NAD+ and 2,2,2-trifluoroethanol  (PDB code: 1SBY). 
Enzyme kinetic studies of DADHs show that the SDR reaction appears to proceed 
through a two substrate compulsory mechanism (Scheme1) [27, 33], where the coenzyme 
binds before the substrate and the product disassociates before the coenzyme.  As shown 
in scheme 1, a proton is released in the oxidation process of alcohols, while a proton is 
taken up in the reduction of aldehydes/ketones. 
Alcohol   +   NAD+ ↔   aldehyde/ketone    +    NADH  +   H+                           (Scheme 1) 
Enzyme kinetic studies of DADHs have also shown that the proton is realised upon 
formation of the binary enzyme•NAD+ (E•NAD+) complex [27, 34, 35], and that most of 
the secondary alcohols tested are better substrates than the primary alcohols [36-38] . 
DADH is a dimer of Mr 54800, consisting of two identical subunits [1, 39, 40].  
The oxidation reaction of DADH includes two steps (Figure 2):  
1. A proton transfer from the alcohol HAlc atom to the strong base or nucleophile 
of the binary E•NAD+ complex.  






Figure 2: Active site geometry of wild type SIADH with the catalytic triad (Ser138, Tyr151, Lys155), 
substrate 2-propanol and parts of NAD+ (PDB: 1SBY). Proposed oxidation reaction mechanism of 2-
propanol by wild type DADH. 
The exact catalytic function of the catalytic triad is not known. Enzyme kinetic 
data have shown that in order to promote hydride transfer from the substrate alcohol to 
the NAD+ molecule, the group (or combination of groups) showing a pKa value of 7.1 in 
the E•NAD+ complex has to abstract a proton from the Cα hydroxyl group of the substrate  
to generate an alcoholate anion R-CH2-O-. This group needs to be negatively charged in 
order to bind the substrate and facilitate hydride transfer from the substrate [27]. Due to 
its position in the active site and the pH dependence of alcohol binding, it was proposed 
that this group is the strictly conserved Tyr151 [19, 20, 31, 41-44]. It was suggested that 
the tyrosine function as the basic catalyst being fully negatively charged, and that the 
lysine binds NAD(P)(H) and lowers the pKa value of the tyrosine, while the serine 
stabilizes the substrate, reaction intermediates and product during catalysis [45].  The 
tyrosine is strictly conserved, whereas Ser and Lys are conserved in most SDRs [9]. 
However, this hypothesis has been challenged by an electrostatic analysis of the 
ionization properties of the active site residues in DADH, using an approach which 
accounts for multiple locations of the hydrogen atoms of ionizable and polar groups [46]. 
Theoretical calculations showed that the protonation/deprotonation transition of the 
E•NAD+ complex is related to the coupled, irregular ionization of the active site groups 




 Eight membered water chain in DADH 1.4
In protein crystal structures, it is now widely accepted that water molecules buried 
inside the protein play an important role in protein stability, dynamics and function [47, 
48]. Water molecules trapped inside protein interiors can fill defects in the side chain 
packing or form  hydrogen bonds to protein polar atoms [49, 50]. The number of water 
molecules included in the protein x-ray crystallographic models depends mainly on the 
resolution of the solved structure [51].   
The exact range of processes mediated by buried water molecules in DADH was 
not known, until 1998, then the x-ray crystal structure of SlADH (PDB Code: 1A4U) 
resolved at 1.9 Å resolution by Ladenstein and his colleagues showed three well-ordered 
water molecules in hydrogen bond distances to side-chains of the catalytic triad [19]. 
With an even higher resolution of the SlADH x-ray structure (PDB Code: 1B16), water 
molecules were also found between NAD+ and the enzyme [20]. Based on these findings 
and kinetic studies, Koumanov and his colleagues proposed a proton relay chain which 
includes the active site catalytic residues, the O2’ ribose hydroxyl group of the coenzyme 
that plays a key role by acting as a proton switch, as well as a chain of eight water 
molecules that connects the active site with the bulk solvent [19, 20, 25, 33, 35, 37, 43, 
46, 52-54] (Fig 3). Later research has shown that the water chain also exists in the ternary 
complex and that all amino acids lining the water are conserved in 119 drosophilid 
species. These findings support the hypothesis of a proton transport in between the active 
site and the solvent mediated by the relay chain [10], and it was suggested that this relay 
mechanism facilitate the proton abstraction from the binary E•NAD+ complex [19, 20, 
46].  A similar water chain has also been shown to exist in human and bacterial SDR 
enzymes [55-57]. This suggests that if not all, but at least part of these buried water 
molecules are conserved between proteins belonging to the same family and they are 






Figure 3: Structure of the water chain in SlADH wild type (PDB Code: 1SBY) at 1.1 Å resolution. The 
water molecules in the chain are shown as green balls and the amino acids involved in the putative proton 
relay system are shown in ball and stick. Dashed arrows show the putative proton transport from Lys155 
through the water chain into the bulk solution. 
 SDRs as drug targets 1.5
Drosophilid has been studied for quite some time as a laboratory model for genetics 
in general and also applied into human diseases studies, like substance addiction, 
Alzheimer’s disease and Parkinson’s disease [58-60]. By 2002, the total number of 
predicted genes of drosophila melanogaster was 13601, among which the number of 
estimated druggable targets were 1714 [61]. Among more than  46,000 primary structures 
of SDR superfamily enzymes identified in sequence databases by 2010, more than 80 
were  found in human [8]. The similarities in sequences, function and protein structures 
within a gene family may often suggest that the binding-site architecture between family 






Figure 4: Protein worm representation of the active site of three SDRs from different family members.  
Grey colored protein worm is 17β-hydroxysteroid dehydrogenase type 1 (PDB code: 1FDT, residues 
displayed are Ser142, Tyr155, Lys159 and Thr189).  Green colored protein worm is SlADH (PDB code: 
1SBY, residues displayed are Ser138, Tyr151, Lys155 and Thr186).  Blue colored protein worm is amyloid 
beta-peptide-binding alcohol dehydrogenase (PDB code: 1U7T, residues displayed are Ser155, Tyr168, 
Lys172 and Thr203). 
This indicates that if one member of a gene family could bind a drug, other 
members with similar active site architecture and function may also be able to bind a 
compound with similar physio-chemical properties [8, 62, 63].  Therefore DADHs can be 
used as model system for the development of new therapeutic compounds targeting 
therapeutical important SDRs [14-17] . In the following I will give a brief introduction 
into the potential of some SDRs as drug targets.  
 17β-hydroxysteroid dehydrogenase type 1 and type 2 as drug targets in 1.5.1
breast cancer 
Breast cancer is a major cause of death in both European and American women, it 
occurs most frequently in post-menopausal women [64, 65] . 17-β-estradiol (E2) 
stimulates the growth of hormone-dependent breast cancer cells [66]. The precursor of E2 
is oestrone (E1). The major enzyme catalyzing the reduction of E1 to E2 is 17-β-
hydroxysteroid dehydrogenase type 1 (17-β-HSD1). The reverse reaction, the 
deactivation of E2 is catalyzed by 17-β-HSD type 2 (17-β-HSD2) (Figure 5) [67]. Both 
17-β-HSD1 and 17-β-HSD2 belong to the family of SDRs requiring NAD(P)(H) as 
cofactor. They are present in healthy premenopausal women, but several studies have 




menopausal women with hormone dependent breast cancer [68-70]. Studies have also 
indicated that that patients with high 17-β-HSD1 expression have significantly shortened 
disease-free and overall survival [71, 72], indicating that compounds that inhibit 17-β-
HSD1 may be therapeutically beneficial in treatment of hormone dependent breast cancer 
in post-menopausal women [73, 74].  
 
 
Figure 5: Inter-conversion of Estrone (E1) and 17 β-Estradiol (E2) catalyized by 17-β-HSD1 or 17-β-HSD2. 
 
Due to the structural and functional similarities of 17-β-hydroxysteroid 
dehydrogenase to other SDRs, the general information obtained from combination of 
theoretical calculations and experimental studies of SDRs from DADHs as model 
systems can then be transferred to enzymes of the 17-β-HSDs family, and may be used 
for structural calculations of binding site geometry and inhibitors design of 17-β-HSD1 
and (or) 17-β-HSD2. 
 Amyloid-β (Aβ) peptide-binding alcohol dehydrogenase as a target in 1.5.2
Alzheimer’s disease 
Numerous studies have indicated the potential importance of amyloid-β peptide 
(Aβ) interaction with a mitochondrial enzyme called Aβ-binding alcohol dehydrogenase 
(ABAD), a member of SDRs family concentrated in mitochondria of neurons [75-82]. Aβ 
distorts ABAD's structure by forming Aβ-ABAD complex, thereby inactivate ABAD's 
metabolic functions and promotes Aβ-mediated cytotoxic events [83, 84]. Particularly, 
increased intracellular Aβ level prior to the appearance of neurofibrillary tangles and 




development [83, 85-88]. An ABAD function inactivated drosophilid scully showed a 
developmentally lethal phenotype with multiple abnormalities [89]. Alternative term for 
ABAD is L-3-hydroxyacyl Coenzyme A dehydrogenase type II [90]. First human ABAD 
x-ray crystal structure was resolved by Kissinger and coworkers in 2004 (PDB code: 
1U7T)  [91]. Like other SDRs or ADHs, ABAD share the same active site features and 
utilize dinucleotide cofactor in catalytic reaction. In metabolic homeostasis, ABAD 
oxydize/reduce a wide range of substrate, such as linear alcohols, steroid substrates (17b-
estradiol), S-acetoacetyl-CoA and β-hydroxybutyrate [90, 92]. ABAD appears to have 
cytoprotective functions under homeo-static conditions and in response to stress [93]. 
Studies of Yao et al. in 2011 showed inhibition of ABAD interaction with Aβ reduced Aβ 
accumulation and improved mitochondrial function in a mouse model of AD [94]. 
Therefore, ABAD could be a potential drug target. The x-ray crystal structure of ABAD 
is known suggesting that computer added drug design could be possible.  
 Enzyme kinetics 1.6
Until 2000,  around 500 drug targets had been reported, among which 28% are 
enzymes [95]. However, only 120 drug targets are actually targeted by marketed drugs 
(47% are enzymes) [61]. Enzymes are powerful biological catalysts that are essential for 
the proper maintenance and reproduction of any organism. These properties make them 
excellent candidates as therapeutic targets to combat diseases. In this regard, one goal of 
molecular medicine is to develop and implement effective agents that can modulate the 
activities of various enzymes involved in essential biological pathways. Therefore, the 
process of drug development often requires accurate knowledge of the catalytic 
mechanism of the enzyme in question. In this study, we mainly focus on the mechanisms 
of two substrate enzymes. 
 Two substrate enzymes and their catalytic mechanisms 1.6.1
Enzymes like oxidoreductases, transferases and ligases catalyze reactions 
involving more than one substrate [96]. These enzymes utilize metal ion or organic 
cofactors as additional substrates. When it comes to the binding order of substrates for a 




displacement mechanism/substituted enzyme mechanism, ii) ternary complex mechanism 
(Figure 6) [96-98]. 
  
Figure 6: Example of catalytic mechanisms of two substrate enzymes. E: enzyme, S1: substrate 1, S2: 
substrate 2, P1: product 1, P2: product 2. 
Ping-pong mechanism occurs when two substrate share one active site. In this 
case, one substrate leaves one moiety (phosphate group, an amino group or acyl group etc) 
on the enzyme to be transferred to the second substrate. In such a case, the two substrates 
do not bind to the enzyme at the same time during the reaction. In the other main type of 
mechanism, the ternary complex mechanism, both substrates must be bound to the 
enzyme at the same time and form a ternary complex (ES1S2) in order to start the 
catalytic reaction. There are various possibilities for the formation of a ternary complex. 
The binding of S1 and S2 either follows sequential order (compulsory-order mechanism), 
or they randomly binds to the enzyme (random-order mechanism). A special case of a 
compulsory-order mechanism occurs when the interconversion of ES1S2 and EP1P2 is 
much faster than all the other steps and no kinetically significant ternary complexes 
appear to occur. This is called a Theorell-Chance mechanism. Enzyme kinetic studies 
provide microscopic views of the factors affecting enzyme-catalyzed reactions. Chemical 
reactions involved enzymes can be quantitatively evaluated by measuring the speed at 
which the reacting substances are transformed to the corresponding products, namely 
reaction rate.  
There are two types of kinetic studies that can be performed:  
Ping Pong 
Random order 
Compulsory order  






(1) Pre-steady state, which is the period when an enzyme-substrate complex is 
formed, there is sometimes some transiently formed enzyme-intermediate complex. This 
period lasts from micro- to milli-seconds. To be able to detect the formed 
enzyme•substrate (ES) complex and probable intermediates, one method is stopped-flow 
kinetics. The enzyme concentration used in this method is usually high and in the region 
of the used substrate concentration;  
(2) Steady state, which is the period during the reaction where there is no change 
in the amount of the formed ES complex and other intermediates. This period often lasts 
from a fraction of a second to several minutes (sometimes hours). Furthermore, the 
enzyme concentration used is much lower than the used substrate concentrations [99, 
100].  
The reaction scheme including rate constant for compulsory-order mechanism 















k9   �⎯�
k10
�⎯� E + P1                              (Scheme 2) 
 
Where E is the enzyme, S1 and S2 are substrates, P1 is the product from S1 and P2 is the 
product from S2, ES1 and EP1 are binary complexes, ES1S2 and EP1P2 are ternary 
complexes, k1 to k10 are rate constants. The catalytic mechanism and experimentally 
observed kinetic behavior can be mathematically expressed by a rate equation that 
depicts the process in terms of rate constant and reactant concentrations.   The rate 
equation that describes the relation between kinetic coefficients and substrate 
concentrations can be written as equation (1) for a ternary complex mechanism and as 
























In these equations, e is the amount of active enzyme, v0 is the initial rate of 
reaction, [S1] and [S2] are the concentration of substrate 1 and substrate 2, respectively. 
φ0, φ1, φ2  and φ12 are kinetic coefficients. In two substrate reactions, the reaction rate v 
is dependent on the concentration of both S1 and S2. This algebraic rearrangement of the 
Michaelis-Menten equation is the mathematical basis for deducing Lineweaver-Burk 
type of plot [102]. Lineweaver-Burk analysis is one method of linearizing substrate-
velocity data so that the kinetic coefficients can be determined by using primary and 
secondary plots (Fig 7) [101, 103]. 
 
                               
 
Figure 7: Plots illustrate the determination of the kinetic coefficients of equation (1) by secondary plots of 
slopes and intercepts (b) of primary Lineweaver-Burk plots (a).    
 
In figure 2, a series of Y intercept and Slope values collected from plot (a) can 
then be introduced into equation (1), where from a secondary plot (b), the value of 
different φ coefficients can then be determined [96]. The physical meaning of φ 
coefficients in a compulsory ordered ternary complex mechanism is listed in Table 2.  
Table 2: The meaning of different kinetic coefficients.  
 
1/φ1 (k1 or kon) 1/φ2 (k2 or kon ) 1/φ0 (kcat) φ1/φ0 φ2/φ0 φ12/φ1 φ2, (koff), k-1 
Formation rate 
of ES1 complex.  
Formation and 

















Disassociation rate of  






















Not only can the characteristics of the rate equation and different kinetic coefficients 
verify the mechanism, conversely, the experimental observations provide clues to what 
the mechanism may be. Another way to verify the catalytic mechanism is to determine 
the reaction velocity in the presence and absence of inhibitors.  
 Enzyme Inhibition 1.6.2
Enzyme inhibitors may act either irreversibly or reversibly [100]. Irreversible 
inhibitors form covalent bonds with different functional groups on the enzyme surface.  
Reversible inhibitors form non-covalent interactions with various parts of the enzyme 
surface, which can be reversed by dilution and dialysis. Reversible inhibitors can either 
be products of the substrates investigated or other type of compounds. Reversible 
inhibitors can give rise to several types of inhibition patterns, and three such patterns are: 
competitive, uncompetitive and mixed inhibition. A product inhibitor pushes the 
reaction backwards while other compounds that react with a specific enzyme form and 
gives rise to an enzyme•inhibitor complex that is not a part of the flow from  substrate to 
product is called a dead-end inhibitor [104]. It is common to use dead-end inhibitors in 
order to investigate  the reaction mechanism of a multi substrate enzyme and if 
substrates bind and products leave in a specific order or not [100].  
 Dead-end inhibition 1.6.2.1
In 1962, Fromm and Zewe suggested that competitive inhibitors of substrates 
could be used to differentiate between random and ordered mechanisms [105]. Because 
dead-end inhibitors cannot reverse reaction sequences (as products for two substrate 
enzymes can), competitive dead-end inhibitors are often used to determine the enzyme’s 
reaction mechanism, especially whether the substrates bind in a specific order or not [99, 
104]. To get a full picture of the binding order of the two substrates to the enzyme, it is 
necessary to check the inhibitory pattern of each inhibitor against varied S1 (fixed S2) 
and varied S2 (fixed S1). In most cases one experiment is performed with low 
concentration of the fixed substrate (compared to its Km value) and another experiment 
with high concentration of the fixed substrate, while the other substrate is varied in the 
presence and absence of inhibitor. The inhibition patterns for a two substrate random 




assume inhibitor I1 only binds to the same site as substrate S1, and inhibitor I2 only binds 
to the same site as substrate S2.  
In a random order mechanism (Figure 8a), if I1 or I2 only binds to the free 
enzyme (E), then both S1 and S2 will compete with I1 or I2 for the free enzyme. 
Therefore, both inhibitors are competitive inhibitors against both substrates and will 
therefor give rise to four competitive patterns (not shown). If I1 binds both to E and ES2, 
then relative to S1 (fixed S2 concentration), I1 shows a competitive pattern (Figure 8b), 
and relative to S2, I1 shows mixed inhibition (with low fixed S1 concentration, Figure 
8d). No inhibition occurs at a high fixed S2 concentration. Similarly, If I2 binds both to 
E and ES1 (Figure 8a), then relative to S2 (fixed S1 concentration), I2 shows a 
competitive pattern (Figure 8e), and relative to S1, I2 shows mixed inhibition (with low 
fixed S2 concentration, Figure 8c). No inhibition occurs at a high fixed S1 concentration.  
In short, if both inhibitors bind to free enzyme and their corresponding binary complex, 
it will give two competitive patterns (i.e. I1 vs S1 and I2 vs S2 in Figure 8b, e) and two 
mixed patterns  (i.e. I1 vs S2 and I2 vs S1 in Figure 8c, d).  An uncompetitive pattern will 
never occur with a random order mechanism. 
 
Figure 8: (a) Reaction scheme for a random-ordered mechanism where S1 binds to the free enzyme E and 
ES2, and S2 also binds to the free enzyme and the binary ES1 complex. Inhibitor 1 (I1) binds to E and 
binary ES2 complex, I2 binds to E and binary ES1 complex. (b-e) double invers plots of v vs a varied 
substrate in the absence (0) and presence (I1 or I2) of inhibitor. Inhibition pattern of I1 vs varied [S1] (b) 
and I2 vs vaired [S1] (c) using a fixed [S2]. Inhibition pattern of I1 vs varied [S2] (d) and I2 vs vaired [S2] (c) 





In a compulsory ordered mechanism (Figure 9), when a competitive dead-end 
inhibitor I1 binds to the free enzyme, it distorts the enzyme so that substrate S1 cannot 
bind to the EI1 binary complex. This makes the inhibitor I1 to compete with the substrate 
S1 (Figure 9b) and it will give a mixed inhibition against substrate S2 (Figure 9d). On 
the other hand, inhibitor I2 competes with substrate S2 (Figure 9c) and does not bind to 
the free enzyme, only to the ES1 binary complex (Figure 9a). In this mechanism, 
inhibitor I2 shows an uncompetitive pattern against substrate S1 (Figure 9c). This unique 
uncompetitive pattern of I2 helps to distinguish a compulsory ordered mechanism from a 
random ordered mechanism. Similarly, I1 shows mixed inhibition pattern against varied 
S2 which means that the inhibitor binds before the varied substrate S2 and that there is a 
reversible connection between EI1 and ES1 as shown  in Fig 9a [104]. 
 
Figure 9: Reaction scheme for a compulsory ordered mechanism where S1 binds to the free enzyme E and 
S2 to the binary ES1 complex. Inhibitor 1 (I1) binds to E and I2 to the binary ES1 complex. (b-e) double 
invers plots of v vs a varied substrate in the absence (0) and presence (I1 or I2) of inhibitor. Inhibition 
pattern of I1 vs varied [S1] (b) and I2 vs vaired [S1] (c) using a fixed [S2]. Inhibition pattern of I1 vs varied 
[S2] (d) and I2 vs vaired [S2] (c) using a fixed [S1].  
 Enzyme-inhibitor dissociation constants 1.6.3
The equilibrium dissociation constant of an enzyme•inhibitor (EI) complex can 
be derived from inhibition kinetic studies, and is then called an inhibition constant, Ki 




constant (Ki = Kd) or an apparent constant (appKi: i.e. Ki ≠ Kd) [103]. This depends on the 
kinetic mechanism and the experimental conditions used.  
For a compulsory ordered two substrate reaction where S1 binds to the free 
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If the concentration of S2 is fixed, then the obtained Ki1 value from the slope of equation 
(3) represents the true dissociation constant (Kd) of the EI complex. This is independent 
of the concentration of the fixed substrate (in this case S2). 
 If competitive dead-end inhibitor binds only to the ES1 binary complex (Figure 
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Inhibitor I2 competes with substrate (S2). In this case, the obtained inhibitor constant Ki2 
does not necessarily represent the true dissociation constant of the ES1I2 complex. The 
reason for that is simply that I2 binds to the ES1 complex. At a low concentration of S1, 
only small amounts of the enzyme are in the form of the binary ES1 complex to which I2 
can bind.  Then the obtained binding constant is weaker than the true binding constant, 




≈ 0 , the obtained Ki2 value  can represent the true dissociation 
constant of the ternary ES1I2 complex. This is because the entire amounts of enzyme are 
in the binary ES1 complex. With a saturating concentration of S1, the strength of the EI 












Where [I] is the inhibitor concentration, si and s0 are inhibited and uninhibited slopes in 
a Lineweaver-bruke plot (Figure 9e), respectively. Here, Kis can be regarded as the 
dissociation constant of I2 from the ternary complex (ES1I2). Ki can also be calculated 
from plot in Figure 9c using intercept term (Kii). The corresponding equation using the 







                                                                                                             (Eqn.6) 
 
Where ii and i0 are the inhibited and uninhibited intercepts. As I2 binds to the ES1 binary 
complex, the mathematical correlation between Kd, Ki and the kinetic coefficients using 
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0), then the obtained Ki = Kd. In all other situations the obtained Ki is an apparent 
dissociation constant (appKi) which is larger than Kd. The larger the Kd the weaker the 
binding. If the kinetic coefficients (kcat, Km or different φ value) for the reaction are 
known, and a Ki value has been obtained from equation (5) using a fixed [S1], the true 





 Application of Molecular modeling in enzyme kinetic studies  1.7
 Docking and scoring 1.7.1
Modern drug discovery often include searching for small molecules that can bind 
to a preselected protein target.  Protein-ligand docking aims to predict and rank binding 
orientation of ligands in a target protein of known 3D structure [106]. Starting from the 
early 1980’s [107], it remains a field of vigorous research, having become a useful tool in 
drug discovery programs [108]. The protein-ligand docking occupies a very special place 
in the field of docking, because of its applications in medicine [109]. From the docking of 
both protein and ligand as rigid bodies [107], protein-ligand docking has developed to an 
area where full flexibility on the ligand is commonly included. Although binding 
orientation and affinity of a given ligand, and binding-site geometry of target protein can 
be greatly influenced by protein flexibility [110], including protein flexibility is still a 
challenge and computationally expensive by most docking programs. The traditional 
lock-and-key and induced-fit theories have given their way to more modern theories that 
bestow a greater weight to the receptor flexibility issue [111]. The current idea interprets 
a protein as an ensemble of differently populated conformational states in equilibrium, 
rather than the stable conformation appearing in X-ray crystal structure [111]. An 
important notion that needs attention is that the conformations of the target protein in the 
protein-ligand complex are not necessarily the most populated conformations in an 
unbound state [110-112]. So, when it comes to docking, these aspects imply that instead 
of targeting a single pose of a given ligand on a single target protein structure, one should 
ideally look for the most populated alternatives from an ensemble of solutions comprising 
several different binding conformations [106]The docking result are mainly judged by 
two factors: (1) the ability to make key hydrogen bonding and hydrophobic contacts and 
(2) the ability to achieve a reasonable root-mean-square deviation (RMSD) which is 
lower than 2 Å  after redocing compounds found in X-ray crystal structure complexes 
[113]. 
Molecular-docking ultimately seeks to predict the best mode by with a given 
compound will fit into a binding site of a macromolecular target. As a result, this usually 
involves two independent steps:   




 Scoring: Evaluate the ligand orientation. 
Scoring is used to evaluate the interaction between a ligand and its target protein by 
ranking how well the ligand fit into the binding pocket or by predicting the absolute 
binding affinity between the ligand and its target protein. Although the standard free 
energy of binding (ΔG) is given by the Gibbs Helmholtz equation (equation 9) [100], the 
predicted binding affinity in terms of ΔG is still an approximation.  
 
ΔG= ΔH – TΔS = −RT ln Ki                                                                                     (Eqn.9) 
 
Where ΔH is the enthalpy, T is the temperature (Kelvin), ΔS is the entropy, Ki is the 
binding constant and R is the gas constant [114]. 
 Glide docking program 1.7.2
Glide (Grid-based Ligand Docking with Energetics) is one of the most widely 
used docking programs. The Glide algorithm approximates a systematic search of 
positions, orientations, and conformations of the ligand in the protein-binding pocket via 
a series of hierarchical filters. The procedure of how Glide works is illustrated in Figure  
10.   
 





A typical scoring function contain terms like: 
 ΔGscore=α1ΔEvdw+ α2ΔEH-bond+ α3ΔEel+ α4ΔErot+ α5ΔEsolv +…                               (Eqn.10) 
Here iα  is weighting factors that can be fitted to actual binding data of specific protein-
ligand systems. The scoring in Glide 5.7 is first carried out in ‘Greedy score’ stage using 
Schrödinger’s ChemScore empirical scoring function [115]. Much as for ChemScore 
[116], this algorithm recognizes favorable hydrophobic, hydrogen-bonding, and metal-
ligation interactions, and penalizes steric clashes. Only a small number of best refined 
poses are transferred to next stage that involves evaluation and minimization of a grid 
approximation to the OPLS-AA non-bonded ligand-receptor interaction energy [117, 
118]. Finally, the minimized poses are re-scored using Schrödinger’s proprietary 
GlideScore scoring function: 
GScore = 0.065*vdW + 0.130*Coul + Lipo + Hbond + Metal + BuryP + RotB + Site         (Eqn.11) 
Here vdw stands for van der Waals energy, Coul is the Coulomb energy, Lipo is the 
lipophillic contact term, Metal is the metal binding term where only the interactions with 
anionic acceptor atoms are included, BuryP is the penalty for buried polar groups, RotB is 
the penalty for freezing rotatable bonds, and Site is the polar interactions in the active site. 
GlideScore is based on ChemScore, but includes a steric-clash term and adds buried polar 
terms devised by Schrödinger to penalize electrostatic mismatches. 
Before initiating the ligand docking, a receptor grid maps must be generated. The 
grid files represent physical properties of a volume of the target protein (specifically the 
active site) that are searched when attempting to dock a ligand. First, the prepared 
structures (both protein and ligand) are imported. The receptor is selected by excluding 
the ligand, while the active site can be defined as the centroid of the ligand.  To increase 
the docking accuracy, different constrain can be added. For example, a hydrogen bond 
constrain can be set between the ligand and an active site amino acid or cofactor of the 
target protein. Other constrains like bond angle and atom position can also be used. The 
calculated target protein grid file is then used to dock the ligands with standard precision 
(SP), high throughput virtual screening (HTVS) or extra precision (XP) docking modes. 
In Glide XP docking, another scoring function called XP Glide-ChemScore  [119] is used. 
This scoring function includes additional terms over the SP scoring function, and a more 




 Molecular Mechanics 1.7.3
The molecular modeler often wants to understand and predict properties of liquids, 
solutions, solids and macromolecules. The experimental properties of a system such as 
the pressure and the heat capacity are determined by the positions and momentas of the 
particles that comprise the system. So the word simulation in turn refers to methods 
aimed at generating a representative sampling of a system at a finite temperature, volume 
and pressure.  
Molecular mechanical methods can be used to search energy minimum of a 
molecular system and simulate molecular behavior. The two main simulating methods 
using molecular mechanics are Monte Carlo (MC) and Molecular Dynamics (MD). These 
simulation methods can be used to overcome energy barriers and find global energy 
minimum and to study random or time dependent structural changes in a molecular 
system. Molecular mechanics calculations are using force fields (also named force field 
methods), and ignore the electronic motions and calculate the energy of a system as a 
function of the nuclear positions only.  Basic functional form of a force field encapsulates 
both bonded terms relating to atoms that are linked by covalent bonds, and non-bonded 
(also called "non-covalent") terms describing the long-range electrostatic and van der 
Waals forces (Figure 11). 
 
Figure 11: Representation of the key contributions to a molecular mechanics force field: bond stretching, 
angle bending and torsional terms, as well as non-bonded terms (Electrostatic and Van der Waals 







The force field can be written as [114]: 
Etotal = Ebonded + Enonbonded 
Ebonded = Ebond + Eangle + Edihedral 
Enonbonded = Eelectrostatic + Evanderwaals 
The total potential energy (Etotal) is the sum of covalent (Ebonded) and non-covalent 
(Enonbonded)  bonding energy terms. Ebonded  represent the sum of bond stretching 
(Ebond) , angle bending (Eangle)  and torsional energy (Edihedral)  terms.  Enonbonded 
refers to electrostatic (Eelectrostatic) and Van der Waals (Evanderwaals) energy terms. A 
force field defines a set of parameters for each type of atom. For example, OPLS-AA has 
a functional form [120]: 
E = � Kr(r − req)2
bonds
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                                                          (Eqn. 12) 
In this equation, the first three terms comprise bonded interactions, while the last term 
describes the nonbonded ones. The first and second terms represent the bond and angle 
terms, in which Kr and Kθ are the bond force constants and valence angle force constant. 
req and θeq are equilibrium values for bond distance and valence angle, respectively.  The 
third part represent the torsional energy terms between atom pairs i and j (i˂j), in which 
φi is the dihedral angle, V1, V2, and V3 are the coefficients in the Fourier series, and f1, f2, 
and f3 are phase angles. The total torsional energy is then the sum of this series for each 
dihedral angle. The sums for the bonded terms are carried out over all atoms involved. 
The intermolecular nonbonded interaction energy between atoms  i  and j  are represented  
by the Coulomb plus Lennard-Jones terms in the last part of the equation, in which qi and 
qj are the partial charges of the atoms i and j involved and e is the vacuum dielectric 
constant. ɛij, σij, fij and rij represent the well depth, collision diameter, scaling factor and 
the distance between the atoms i and j. The scaling factor fij equals 0.5 for 1,4 interactions 
and one otherwise. The non-bonded term is calculated between all pairs of atoms (i and j) 




 Global energy minimum 1.7.3.1
In molecular modeling we are especially interested in minimum points on the 
energy surface. Minimum energy arrangements of the atoms correspond to stable states 
of the system, any movement away from a minimum gives a configuration with a higher 
energy [114]. The minimum with the very lowest energy is known as the Global energy 
minimum. The way in which the energy varies with the coordinates is usually referred to 
as the potential energy surface. Most optimization methods try to determine the minima 
point, but for a large system, the potential energy is a complicated, multi-dimensional 
function of the coordinates. Therefore, energy landscapes for large system are extremely 
complex, and finding a minima can be a challenging task, finding the global minimum is 
even more challenging [121, 122]. Many variables are used in computational chemistry 
optimization methods. Basically all methods assume that the first derivative (i.e. the 
gradients) of the function with respect to all variables can be calculated. More 
sophisticated methods  also assume the second derivative matrix, the Hessian matrix 
(force constant matrix) [123], can be calculated. Most commonly used global minimum 
searching algorithm includes: steepest descent (SD) method, conjugate gradient (CG) 
method and Newton-Raphson (NR) method [114]. CG and SD minimizations operate in 
Cartesian space rather than internal coordinates. They are much faster than the other 
methods. As a second derivative method, NR method uses not only the first derivative but 
also the second derivative (i.e. the Hessian matrix) to locate a minimum. Due to large 
amount of calculation of the full second derivative matrix which must be stored and 
inverted, this can be computationally demanding for systems with many atoms. Hence, 
the NR method is more suited to small molecules (usually less than 100 atoms or so). 
 Monte Carlo simulations 1.7.3.2
Monte Carlo (MC) statistical mechanics methods typically employ a classical 
potential energy function for bond stretching, angle bending, torsions, and non-bonded 
interactions [124]. A MC simulation generates a new configuration by a set of random 
motions. The difference in energy between the new and the old configuration is used as a 
selection criterion by the Metropolis algorithm [125], which enforces a correct 
Boltzmann distribution of energies for the system at the desired temperature, and the 




Although MC methods have the advantage of using energy as basic information and 
random sampling of coordinates, sampling for large flexible molecules can be 
problematic since degrees of freedom will increase. The MC method doesn’t consider 
atomic velocities and the time dimension.  
 Molecular dynamics simulations  1.7.3.3
The MD method calculates the time dependent behaviour of a molecular system. 
It is based on Newton’s second law or the equation of motion, Fi=miai, where Fi is the 
sum of all forces exerted on atom i that results in its acceleration ai, mi is its mass. From 
knowledge of the force on each atom, it is possible to determine the acceleration of each 
atom in the system. The acceleration is the second derivative of the position with respect 







                                                                                                 (Eqn.13) 
In words, it is the rate of change of the velocity vi, which in turn, is the rate of change of 
the position ri.. Integration of the equations of motion then yields a trajectory that 
describes the positions, velocities and accelerations of the particles as they vary with time. 
From this trajectory, the average values of properties can be determined. 
The MD method was first introduced by Alder and Wainwright in the late 1950's 
[126, 127] to study the interactions of hard spheres. Many suggestions concerning the 
behaviour of simple liquids emerged from their studies. The next major advance was in 
1964, when Rahman carried out the first simulation using a realistic potential for liquid 
argon [128]. The behaviour of the particles in hard-sphere potential moves straight in 
lines at constant velocity between collisions. The collisions are perfectly elastic and occur 
when the separation between a pair of spheres equals the sum of their radii [114]. This 
simple model of hard spheres has given useful insights into hard-sphere particle 
movements, but is obviously not ideal for simulating atomic or molecular systems.  
The first MD simulation of a realistic system was done by Rahman and Stillinger 
in their simulation of liquid water in 1974 [129]. The first protein simulations appeared in 
1977 with the simulation of the bovine pancreatic trypsin inhibitor (BPTI) [130]. Today 
in the literature, one routinely finds MD simulations of solvated proteins, protein•DNA 




thermodynamics of ligand binding and the folding of small proteins. MD techniques are 
also widely used as a supplement to experimental procedures such as X-ray 
crystallography and NMR structure determination. MD simulation can fold extended 
sequences to global potential energy minima for very small systems (peptides of length 
ten, or so, in vacuum) [131, 132], but it is most commonly used to simulate the dynamics 
of known structures. 
The number of simulation techniques has greatly expanded; today there exist  
many specialized techniques for particular problems, including mixed quantum 
mechanical - classical simulations (i.e. quantum mechanics and molecular mechanics) 
that are being employed to study enzymatic reactions in the context of the full protein 
[133].  
 Combined quantum mechanics and molecular mechanics 1.7.4
One of the main problems in computational chemistry is to find a balance 
between the accuracy of the results and the computational cost. However, it is often not 
possible to increase the accuracy of the calculation when large systems are considered. 
The idea of combining different computational methods starts with the realization that 
various regions of the system play very different roles in macro-biomolecules. Examples 
of such are most enzymatic reactions, where the bond breaking and forming takes place 
only at the active site. Therefore, the expensive computational methods can be used for 
the part of the system where the action takes place, while less expensive methods can be 
used for the supporting regions.  In 1976 Warshel and Levitt introduced a hybrid 
quantum mechanics and molecular mechanics (QM/MM) methods that treated the active 
part of the system using a quantum mechanical representation while the rest of the system 
was represented by an empirical force field [134]. 
Quantum physics provides a mathematical description of the wave/particle duality 
and interactions of energy and matter. It departs from classical physics, primarily at the 
atomic and sub-atomic scales. Quantum mechanics (QM) explicitly represents the 
electrons in a calculation, and so it is possible to derive properties that depend upon the 
electronic distribution and, in particular, to investigate chemical reactions in which bonds 




few hundred atoms. The application and evaluation of QM/MM method against 
experimental data started only after 1990s [135-139]. 
 General principles 1.7.4.1
The basic idea by using the hybrid methods is that a system is partitioned into 
several regions. The simplest approximation is to divide the system into three regions: a 
QM region, an MM region and the boundary region between QM-MM region (Figure 
12 ). 
 
                                  
Figure 12: Defining the bio-molecular system into QM, MM and boundary regions. 
Because of the strong interaction between QM and MM region, the total energy of 
the entire system cannot be written simply as the sum of the energies of these regions. 
Special precautions have to be taken at the boundary region, especially if it cuts through 
covalent bonds. Depending on the type of QM/MM method, this boundary may contain 
additional atoms (link atoms) that cap the QM region, or it may consist of atoms with 
special features that appear in both the QM and the MM calculations. Table (3) shows the 













Table 3: The commonly used methods applied on the QM regions, MM regions and boundary regions  
QM region 
Density function theory (DFT) [140] , Hartree-Fock (HF) [141, 142], 
Møller-Plesset perturbation theory (MP) [143-145], Austin model 1 
(AM1) [146-150], parametric method number 3 (PM3) [151-153], 
Self-consistent charge density-functional tight binding method (SCC-
DFTB) [154-157], INDO/S-CIS method [158, 159], symmetry-
adapted cluster−configuration interaction method (SAC−CI) [160-
162], time-dependent DFT (TD-DFT) [163-165], multi-configuration 
ab initio methods (e.g., CASSCF or CASPT2) [166-168], Multi-
reference ab initio methods (e.g., MRCI) [169] 
Boundary region 
Link atom method [135, 170], boundary-atom method [171-175], 
frozen localized orbital method [134]. 
MM region  
AMBER [176-178], CHARMM [179-181], OPLS-AA [120, 182], 
GROMOS [183], EFP [166], UFF [143, 184-186] 
 
 The QM/MM energy expression 1.7.4.2
Two types of QM/MM energy expression schemes are described in the literature  
[187]: the additive and subtractive schemes.  
The basic energy equation for an additive QM/MM scheme has been mentioned 
by Warshel and Levitt [134], Field, Bash and Karplus [135], Singh and Kollman [170]: 
 
 𝐸𝑄𝑀/𝑀𝑀𝑎𝑑𝑑 =  𝐸𝑀𝑀 + 𝐸𝑄𝑀 + 𝐸𝑄𝑀−𝑀𝑀                                                                      (Eqn.14) 
 
Where 𝐸𝑀𝑀 is the energy of MM region, 𝐸𝑄𝑀 is the energy of QM region, 𝐸𝑄𝑀−𝑀𝑀   is the 
QM-MM coupling term or interaction energy between QM and MM region in the 
boundary region. When 𝐸𝑀𝑀  is considered in the force field, 𝐸𝑄𝑀−𝑀𝑀  term includes 
bonded, van der Waals, and electrostatic interactions between QM and MM region: 
 
𝐸𝑄𝑀−𝑀𝑀 = 𝐸𝑄𝑀−𝑀𝑀𝑏𝑜𝑛𝑑 + 𝐸𝑄𝑀−𝑀𝑀𝑣𝑑𝑤 + 𝐸𝑄𝑀−𝑀𝑀𝑒𝑙                                                             (Eqn.15) 
 
Most of the QM/MM methods presently in use (including the method in this study) are of 




A subtractive QM/MM energy equation was described by Morokuma and co-
workers [188] : 
 
𝐸𝑄𝑀/𝑀𝑀𝑠𝑢𝑏 = 𝐸𝑀𝑀
𝑠𝑦𝑠 + 𝐸𝑄𝑀 − 𝐸𝑀𝑀
𝑄𝑀                                                                                  (Eqn.16) 
 
Where 𝐸𝑀𝑀
𝑠𝑦𝑠 is the energy from MM calculation of the entire system, 𝐸𝑄𝑀 is the energy of 
QM region, 𝐸𝑀𝑀
𝑄𝑀  is the energy of MM calculation on the QM region. The advantage of 
subtractive scheme is its simplicity, which means no explicit QM-MM coupling terms 
(Equation 14) are needed. On the other hand, the disadvantage is that handling the 
boundary region totally at MM level is particularly problematic when electrostatic 
interaction exists. 
 Application of QM/MM method 1.7.4.3
A large amount of work has to be done to perform QM/MM calculation; this 
includes the preparation of the system before the actual QM/MM calculations are taking 
place and the appropriate combination of QM and MM methods, as well as the treatment 
of the boundary region. Although errors and wrong choices from the beginning can 
hardly be recovered at the later stages, the unique features and promising accuracy of 
these methods have attracted many researchers for its application in studies of chemical 
reactions. Some excellent agreements were obtained between experimental studies and 
theoretical QM/MM calculations. These examples include reaction barriers studies of 
chorismate mutase (CM) and para-hydroxybenzoate hydroxylase (PHBH) [189], and the 
catalytic reaction mechanism of cytochrome P450cam [190]. Since QM/MM methods 
were introduced into enzymatic reaction studies about 30 years ago, the number of 
publications has been rapidly growing covering a wide range of bio-molecular systems, 
such as oxidoreductases [191-199], transferases [142, 144, 200-202], hydrolases [203-
205], lyases [206-208], isomerases [146, 147, 209-214], photoactive proteins [163, 215-





 Aims of study 2
Several therapeutically important drug targets of the SDR family have large 
structural similarities with DmADH and SlADH. That indicates that DmADH and SlADH 
can be used as model systems for therapeutically important SDRs. Insight into the 
structure and function of DmADH and SlADH may therefore contribute with valuable 
knowledge for the development of new drugs targeting SDRs. We and others have been 
studying the enzymatic mechanisms and structure of DmADH and SlADH for years [19, 
21, 22, 25, 33, 35, 37, 43, 52-54, 230], and a quit clear picture about how these enzymes 
function has been obtained. However, there are still puzzles that need to be solved.    
All DADHs contain an eight-membered water chain connecting the active site with 
the solvent at the protein surface. A similar water chain has also been shown to exist in 
other SDR enzymes including therapeutically important SDRs. The role of this water 
chain in the enzymatic reaction is unknown, but it has been proposed to be involved in a 
proton relay system facilitating proton transport between the active site and the solvent 
[46]. Previously, site-directed mutagenesis studies targeting the catalytic triad, co-enzyme 
binding site and other amino acid in DADH were used to study DADH function [29-31, 
231-236]. If the water relay mechanism is important for the oxidation reaction of DADH, 
site-directed mutagenesis studies replacing side chains lining the water chain (for 
example Thr114) would have an effect on the oxidation of substrates and/or destabilize 
the protein structure by disrupting the internal cavity structure, and effect the kinetic 
properties of the enzyme. Our collaborators in Spain (Roser Gonzalez-Duarte and Neus 
Cols) have constructed a mutant SlADH enzyme where Thr114 has been mutated to Val,  
(SlADHT114V mutant) and the X-ray structure of this mutant has been solved by the group 
of Rudolf Ladenstein in Sweden. Thr114 is lining the eight-membered water channel and 
mutating Thr114 to Val should break important hydrogen bonds taking part in the 
putative relay.  
The oxidation reaction of DmADH and SlADH includes two steps (Figure 2).  1. A 
proton transfer from the alcohol to the strong base or nucleophile of the binary E•NAD+ 
complex (the proton transfer step). 2. The hydride transfer from the alcohol to the C4 




break chemical bonds and facilitate the hydride and proton transfer. However, it is not 
clear which step takes place first in the oxidation reaction. 
Theoretical calculations are important compliments to experimental studies, 
especially for processes that are impossible or too expensive to study by experimental 
methods.  The QM/MM approach has become a valuable complement to experimental 
studies for studying chemical reactions involving bond breaking and forming of new 
bonds. The QM/MM approach contributes with structural insights into such processes.  
MD methods are valuable approaches for studying molecular motions of importance for 
ligand binding and molecular mechanics of action of an enzyme.  
     
The specific aims of the present thesis are: 
(1) Use enzyme kinetic methods to study the mechanisms of the SlADHT114V 
mutant, and compare the results with corresponding studies of wild type 
(SlADHwt). In that way we may be able to determine the effect of the mutation 
on the enzyme kinetic mechanism and thereby the importance of the eight 
membered water chain for the enzyme kinetics of SlADH. 
(2) Study the effects of the Thr114 to Val mutation on the molecular dynamics of 
the enzyme by the use of comparative MD simulations of both SlADHwt and 
SlADHT114V mutant MD simulations of the free enzymes, binary E•NAD+ 
complexes and ternary E•NAD+•Alcohol complexes should be performed. 
(3) Study the proton and hydride transfer of SlADH using the theoretical 




 Materials and method 3
In the following a summary of the methods used in the present thesis is given. 
 Experimental studies of the Thr114Val mutant 3.1
 Determination of kinetic constants of substrates 3.1.1
 The oxidation of alcohols and the reduction of acetaldehyde by the SlADHT114V 
mutant were studied by steady state kinetics at 23.5 °C. The initial rates were measured 
by following the appearance and disappearance of NADH, respectively, using a Perkin 
Elmer λ-16 Spectrophotometer. Buffers used were 0.1 M pyrophosphate (pH 8.5 - 10.0), 
or 0.1 M phosphate (pH 6.5 - 8.0). The reported aldehyde concentrations represent the 
sum of the free and hydrated species present. 
 In all experiments, the Lineweaver-Burk plots obtained were linear within the 
experimental error. The data fitted equation (1). The unprimed symbols (φ, S) are used 
for the NAD+ / alcohol reactions and the primed symbols (φ', S') are used for the NADH / 
aldehyde reactions. The kinetic coefficients in equation (3) were obtained from primary 
and secondary plots [237]. The concentrations of coenzyme and substrate used were 
within the following ranges: NAD+ 0.24-6.0 mM, ethanol 5-500 mM, propan-2-ol 0.3-40 
mM,  [2H8]propan-2-ol 1-40 mM, [2H6]ethanol 20-500 mM for the alcohol / NAD+ 
reactions and NADH 1.5-20 μM,  acetaldehyde 0.3-5.0 mM,  for the aldehyde / NADH 
reactions. Inhibition experiments were carried out with either a constant NAD+ 
concentration and varied ethanol concentrations, or constant ethanol concentration and 
varied NAD+ concentrations. 
 Active site titration 3.1.2
Due to sample contamination and changing of physical conditions (like freeze 
drying), a certain proportion of the enzyme may denaturate. During such conditions, the 
enzyme concentration will be overestimated if it is based on the spectrophotometric 
method.  For the determination of the kinetic coefficients and catalytic properties of an 
enzyme, it is absolutely necessary to be able to determine the active-enzyme 
concentration precisely.  The best way to do this is to determine the active site 




concentration to a rate assay [103].  Example of this method is spectrophotometric 
titration [238, 239]. The absorption and difference spectra (Perkin Elmer λ-16 
Spectrophotometer) revealed that the formation of the ternary 
SlADHT114V•NAD+•Pyrazole complex was accompanied by an absorption peak at 305 
nm as previously described for the SlADHwt and drosophilid melanogaster alcohol 
dehydrogenase (DmADH) [37, 239, 240]. The mutant SlADHT114V enzyme containing 
100 mM pyrazole was therefore titrated at 305 nm with NAD+ in 0.1 M Tris/HCl buffer 
pH 8.5 at 23.5 °C. The titration experiments were performed in duplicate, with 
reproducibility within 3 %. The linear parts of the titration curves were analysed by 
linear regression resulting in regression coefficients better than 0.99. Based on the 
titrations with the SlADHT114V mutant enzyme and the assumption that the mutant 
enzyme has the same ε280nm coefficient as the SlADHwt enzyme (ε280nm = 13.3 x 104 M-1 
cm-1) [37], it can be concluded that one NAD+ molecule was bound to each enzyme 
subunit. Hence, there are two active sites per enzyme molecule as the enzyme is a dimer. 
 Rate assay 3.1.3
 The rate assay was based on the active site concentrations determined in the 
titration experiments. The rate assay (performed in duplicate with reproducibility within 
5%) was carried out at 23.5°C with a varied concentration of enzyme and a fixed 
concentration of 1.0 mM of NAD+ and 100 mM of ethanol in a total volume of 1 ml of 
0.1 M glycine/NaOH buffer, pH 9.5. The velocity v (ΔA340nm/min) is a linear function of 
[e], the enzyme active site concentration in the cuvette. As v = k [e], a plot of v against [e] 
gave a rate constant k of 0.192 (ΔA340nm/min per μN enzyme active sites), with a regression 
coefficient greater than 0.99. The enzyme concentration is expressed as the amount of 
subunits in nM. This is twice the amount of enzyme molecules as the enzyme is a dimer. 
 Molecular modeling 3.2
Most of the graphical interpretation and the RMSD calculation of different enzyme 
complex were created by using ICM software Version 3.5 (www.molsoft.com). However 
the molecular modeling calculations like docking, MD simulations, structure 






The X-ray crystal structures of the SlADHwt (PDB code: 1SBY) and the 
SlADHT114V mutant (PDB: 3RJ9) were used as starting structures for computational 
studies. Both X-ray crystal structures were first optimized with protein preparation 
wizard in the Maestro V9.1 [242]. Epic [243] was used to model and optimize the three 
dimensional structures of ethanol and 2-propanol. The 1SBY X-ray crystal structure is a 
ternary complex containing NAD+ and the inhibitor 2,2,2-trifluoroethanol, while the 
SlADHT114V mutant X-ray structures is a binary E•NAD+ complex. The 2,2,2-
trifluoroethanol molecule from the crystal structure was manually adjusted and optimized 
to 2-propanol, while ethanol was manually created and optimized. Ethanol and 2-
propanol were docked into the active site of both the wild type and mutant using Glide 
[244]. The best docking poses were selected based on scoring, similarities with the 
ternary X-ray complex (1SBY) and on the positions of the hydroxyl group and the CAlc 
atom of the alcohol relative to the C4NAD atom of NAD+ and the catalytic triad (Ser138, 
Ty151 and Lys155). 
 MD simulations 3.2.2
The best docking conformation of 2-propanol and ethanol in both the SlADHwt 
and the SlADHT114V mutant enzymes were selected for MD simulations. The systems 
were solvated in SPC water molecules in a simulation box of 10Å×10Å×10Å. All the 
simulations were performed with  Desmond [245] for  a total of 50 ns (far time step 6fs), 
using the OPLS-2005 force field [120, 182], under constant pressure of 1 bar and a 
temperature of 300 K, thermostatted and barostatted using the Nose-Hoover chain [246] 
and Martyna-Tobias-Klein methods [247]. The short-range and long-range Coulombic 
interactions were calculated with cutoff (cutoff radius: 9Å) and Smooth particle mesh 
Ewald [248] methods (Ewald tolerance: 1e-9). All the model systems were relaxed before 
the simulations using default protocol.  
 QM/MM calculation 3.2.3
The best docking conformations of ethanol and 2-propanol with the SlADHwt and 
the SlADHT114V mutant were chosen for QM/MM calculation with Qsite [249, 250]. The 
QM part consisted of (1) the alcohol molecule (2) NAD+; (3) side chains of Ser138, 




or nucleophile and was therefore negatively charged during the calculations. The four 
complexes were initially optimized by Qsite and then the QM/MM relaxation scans were 
performed for two scenarios (the atom labeling is shown in Figure 2):  
 
Scenario 1. The proton (HAlc) transfer from the alcohol donor oxygen (OAlc) to the 
negatively charged acceptor oxygen on Tyr151 is followed by the hydride (HCAlc) transfer 
from the donor atom (CAlc) to the NAD+ acceptor atom (C4NAD). 
Scenario 2. The hydride transfer from the CAlc to the C4NAD is followed by the 
proton transfer from OAlc to OTyr151− . 
Density functional theory (DFT) with the B3LYP function [251] was used for the 
QM part since this method is particularly useful for studying protein active-site reactive 
chemistry, while the OPLS-2005 force field [252] was employed for the MM part of the 
enzyme. The total amount of atoms at QM region was 101. The different atomic bonds 
were scanned with stepwise increments of 0.02 to 0.052 Å. Non-bonded cut off was not 
used. It is strongly advised to not use non-bonded cutoff in the QM/MM job settings, 
because it may create trouble in the optimization and sometimes in the final total energy 
[253]. The polarization basis sets 631G** [254] was used for all atoms treated quantum 
mechanically. The QM/MM energy was converted from Hartrees to kcal/mol by using 





 Summary of results 4
 Paper 1 4.1
Title: An Intact Eight-Membered Water Chain in Drosophilid Alcohol Short Chain 
Dehydrogenases/Reductases is Essential for Optimal Enzyme Activity 
 Pyrazole and 4-bromopyrazole which were ethanol competitive inhibitors with the 
SlADHT114V mutant enzyme in the pH region 7.0 to 9.5, showed uncompetitive inhibition 
against varied NAD+ concentrations in the same pH region. The SlADHT114V mutant’s 
oxidation reaction mechanism was consistent with a compulsory ordered mechanism over 
the entire pH region, where the coenzymes bind to the free enzyme following the 
substrate binding.  
 During the oxidation of alcohols, the kinetic coefficients showed that the kon 
velocity for NAD+ (1/φ1) was approximately 30 times slower for the mutant than for the 
wild type enzyme over the entire pH region. Furthermore, NAD+ binds weaker to the 
mutant than to the wild type enzyme, i.e. the KE,O is larger. The kon velocity for NAD+ 
increases with increasing pH for mutant enzyme, which was  also observed for the 
SlADHwt and slow alloenzymes from Drosophila melanogaster (DmADHS) [27, 34, 35]. 
For both the wild type and the mutant, 2-propanol was a better substrate than ethanol. 
The rate limiting step (1/φ0) for ethanol was the hydride transfer step and for 2-propanol 
enzyme-NADH dissociation step. The kinetic coefficient φ0 for the oxidation of ethanol 
and propan-2-ol did not vary within the pH region studied. The hydride transfer step has 
been reduced by approximately 4 times from 2.4s-1 in the SlADHwt enzyme to 0.6s-1 in 
the SlADHT114V mutant. The rate of the enzyme-NADH dissociation step was the same 
for both mutant and wild type.  
The pKa value of 7.1 ± 0.1 for the wild-type enzyme [34] has been changed to 7.9 
± 0.1 for the mutant. With the SlADHT114V mutant a primary kinetic isotope effect of 3.5 





 Paper 2 4.2
Title: Comparative molecular dynamic simulations of wild type and Thr114Val 
mutated Scaptodrosophila lebanonensis alcohol dehydrogenase 
 MD simulations were performed for the free enzymes, binary E•NAD+ complexes, 
ternary enzyme•NAD+•2propanol (E•NAD+•2pro) complexes and ternary 
enzyme•NAD+•Ethanol (E•NAD+•Eth) complexes of both the wild type and mutant 
enzyme. 
In the free enzyme simulation: for the SlADHwt, the RMSD of the backbone 
stabilized around 2.3-2.7 Å, while the backbone RMSD of the SlADHT114V mutant varied 
between 2.1 and 2.9 Å (Figure 1 in paper2).  Compared with Thr114 in the wild type, 
Val114 in the mutant is lacking a hydroxyl group and only a hydrogen bond between 
backbone NH of Val114 and the backbone CO group of Gly 110 was seen. This hydrogen 
bond was also maintained during the entire 50 ns of MD.  
In the wild type E•NAD+ binary complex, the adenine part of NAD+ formed 
hydrogen bonds with Asp63 and Val64 that persisted during the entire 50 ns of MD, 
while these hydrogen bonds were broken after around 4 ns in mutant and were not seen 
for the rest of the MD. The nicotinamide part of NAD+ formed a hydrogen bond to 
Thr186 during MD of both the wild type and mutant binary complex. The hydrogen bond 
seemed more persistent during MD with the mutant binary complex than during MD with 
the wild type binary complex.  In the region of amino acid 114 (mutation region), Gly110 
interacted mainly with Thr114 by forming two hydrogen bonds in wild type. In the 
mutant, Gly110 interacted with Asn113 and the back bond NH group of Val114. RMSF 
profile showed reduced fluctuation of the region around amino acids 175 -195 that is 
located on the protein surface being important for binding the nicotinamide part of NAD+ 
during MD with the mutant compared with that of the wild type (Figure 4 in paper2). 
In the E•NAD+•2pro complex, the hydrogen bonds between the adenine part of 
NAD+ and Asp63/Val64 were stable during MD with the wild type, while in the mutant, 
these interactions were gradually reduced. For the wild type the RMSD for NAD+ was 
between 0.0 Å to 2.0 Å, while for the mutant the RMSD for NAD+ was between 0.5 Å to 
2.5Å. The side chain carbon atoms of the hydrophobic amino acids Ile106 and Val64 




the atomic distance between their closest side chain carbon atoms was continuously 6 Å, 
while the corresponding distance in the mutant was 6 Å during the first 10 ns, then it 
dropped to around 4.5 Å for the rest of the simulation. Both the side chain OH group and 
the backbone NH group of Ser71 formed very stable hydrogen bonds with Pro67, while 
in the wild type, only the backbone NH group interacted stably with Pro67, while the side 
chain was in the direction of Tyr62 altering the position of Tyr62 compared with the 
mutant. The interaction between Gly110 and Thr114 in the wild type remained the stable 
during the entire 50 ns of MD, while in the mutant, Gly110 interacted not only with 
Val114 backbone -NH group, but also with Asn90 and a water molecule during MD.  
After 12 ns of simulation with the ternary E•NAD+•Eth complex of the mutant, the 
hydrogen bonds between the adenine part and Asp63 and Val64 were broken, while the 
hydrogen bond between nicotinamide part and Thr186 was not observed between 10 and 
20 ns, but were for the rest of the simulation. Calculations of the RMSD of NAD+ during 
MD of the mutant showed an increase from 0.5 Å to 2.5 Å during the first 7 ns, for the 
rest of the MD the RMSD was stable between 2.5~3.5Å. In the wild type, the interactions 
of the nicotinamide part of NAD+ with Thr186 and the interactions of the adenine part 
with Asp63 and Val64 were stable during the entire 50 ns of simulation.  The side chain 
atomic distances Ala92 - Val64 and Ile106 - Val64 were quite stable during MD with the 
wild type ternary complex, while during MD with the mutant these distances increased 
from 4 to 8 Å (Ala92-Val64) and from 6 to 10 Å (Ile106-Val64). Gly110 in the mutant 
interacted with Asn90 during the first 30 ns, and then changed to the backbone NH group 
of Val114. During MD with the wild type, Gly110 mainly interacted with Thr114.    
The catalytic triad (Ser138, Tyr151 and Lys155) remained quite stable in both wild 









 Paper 3 4.3
Title: QM/MM studies of the catalytic mechanism of short chain alcohol 
dehydrogenases 
After docking, the HAlc (Figure 2) of both 2-propanol and ethanol was located at a 
distance of 1.59 Å from the OTyr151−  atom in the wild type. In the ternary SlADH
T114V 
mutant complexes, the HAlc of both 2-propranol and ethanol was located around 1.50 Å 
from the OTyr151−  atom.  
      In scenario 1a (Figure 2 in paper 3) , QM/MM energies for E•NAD+•2pro wild type 
complex increased by approximately 7 kcal/mol when going from the energy optimized 
complex until the complex with the HAlc–OTyr151−  atomic distance of 0.95 Å was obtained. 
During the successive decrease of the HAlc–OTyr151−  atom distance, the CAlc–OAlc atomic 
distance decreased automatically from 1.44 to 1.40 Å. However, the CAlc–HCAlc and 
HCAlc–C4NAD atomic distances did not change. The energy developments during the 
relaxation scan 1b for 2-propanol indicated that activation energy of about 20 kcal/mol 
was  needed, then the energy drops with approximately 17 kcal/mol until a stable HCAlc – 
C4NAD atomic distance of 1.10 Å was  formed. 
In scenario 2a (Figure 2 in paper 3), at an HCAlc –C4NAD atomic distance of 1.095 Å 
the QM/MM energy reached minimum. Between increment step 18 and 19 of 2-propanol 
with the wild type enzyme, the HCAlc–C4NAD atomic distance changed from 1.47 to 1.42 
Å, but the HAlc– OTyr151−  distance changed from 1.43 Å (increment 18) to 1.029 Å 
(increment 19), while CAlc–OAlc changed dramatically from 1.39 to 1.32 Å and the OAlc–
HAlc atomic distance changed from 1.067 Å to 1.52 Å (Figure 5 and 6 in paper 3). Similar 
sudden changes in the region of the alcohol hydroxyl group were also observed during 
the HCAlc–C4NAD distance relaxation scan of other wild type and mutant ternary 
complexes. At the end of the relaxation scans when the QM/MM energy had reached the 
energy minimum, at a HCAlc–C4NAD atomic distance of 1.095 Å, the HAlc– OTyr151−  
distances were: wild type E•NAD+•2pro complex: 0.98 Å, the wild type E•NAD+•Eth 
complex: 0.98 Å, the mutant E•NAD+•2pro complex 0.99 Å and the mutant E•NAD+•Eth 
complex 0.97 Å (Figure 4 in paper 3). During the relaxation scan the CAlc–OAlc changed 




calculations indicated that a double bond character was induced into CAlc–OAlc bond 
before the HCAlc–C4NAD relaxation scan was ended. For the ternary complex of 
E•NAD+•2pro with the wild type enzyme, a CAlc–OAlc double bond was formed between 
increment steps 19 to 23. During these steps, the CAlc–OAlc bond distance change from 
1.33 Å to 1.24 Å, while HCAlc–C4NAD bond distance changed from 1.42 Å to 1.21 Å, 
while the hydride transfer relaxation was continued until an HCAlc–C4NAD atomic distance 
of 1.105 Å at increment step 25. A similar change in the hydride transfer was not 



























The SDR family is the best studied family of the ADHs, and several review papers 
have covered this group of enzymes during the last years [8, 10, 62, 255-257]. With the 
fast development of genome projects, the number of identified SDR primary sequences 
has increased from around 2000 [255] to around 47000 [8] during the last ten years. 
These primary sequences come from a variety of different species. A web site based on 
SDR related research has also been constructed (http://www.sdr-enzymes.org/).  
In humans there are, so fare, 202 SDR forms, among which 24 enzymes are 
associated with diseases in the OMIM database (Online Mendelian Inheritance in Man) 
[8]. However, the functions of about half of the human SDR enzymes are unknown [8]. 
Therefore, understanding the function and chemical reaction mechanism of SDR is also 
medically very important. Studies from different species have indicated that most 
enzymes in the SDR family have large similarities in the active site architecture (Figure 
4), and are either NAD+ or NADP+ specific or utilize both coenzymes [8, 10, 62, 255-
257]. Based on these similarities it is reasonable to believe that SDRs from drosophilid 
species may be used as a model system for other enzymes in the SDR family. 
SDRs from drosophilid species are among the most convenient to study. In these 
SDRs the nucleotides stereospecifically transfers a hydride from or to a substrate carbon 
atom and position 4 of the nicotinamide ring, and a lot is known about their molecular 
mechanism of action. However, the exact mechanism is still unknown. A chain of eight 
water molecules that is conserved in all DADHs has been proposed to be involved in a 
proton relay mechanism transporting a proton in between the active site and the solvent 
[19, 20, 46]. In the present study, the SlADHT114V mutant was studied by experimental 
enzyme kinetic studies and theoretical molecular modeling studies, while the SlADHwt 
was studied by theoretical molecular modeling studies.  The main focus was on the 
function of this water chain and on the proton transfer and hydride transfer steps during 





 The eight membered water chain in DADHs 5.1
 Enzyme Kinetic studies of SlADHT114V 5.1.1
Highly pure preparations of SlADHT114V mutant were obtained from one of our 
collaborators. The proton relay chain in the SlADHwt is shown in Figure 3. The resolved 
X-ray crystal structure of the SlADHT114V mutant (Figure 13) shows high similarity to the 
structure of the wild-type enzyme (Figure 3), although the eight-membered water chain in 
the SlADHT114V mutant is interrupted by the lack of the hydroxyl group at the side chain 
in position 114.  However, differences in the kinetic properties between SlADHwt and   
SlADHT114V were found. 
 
Figure 13: Eight membered water chain in X-ray crystal structure of SlADHT114V mutant (PDB Code: 
3RJ9). 
Pyrazole and 4-bromopyrazole which were ethanol competitive inhibitors with the 
SlADHT114V mutant enzyme in the pH region 7.0 to 9.5, showed uncompetitive inhibition 
against varied NAD+ in the same pH region, and not mixed inhibition pattern. Therefore, 
like the wild type [19, 21, 33, 37, 54, 230], binding of coenzyme and substrate to the 




(Scheme 2, Figure 6) with the coenzyme binding to the free enzyme before the substrate 
binding. This is valid for the entire pH region studied. This was further proved by the 
independency of φ1 coefficient (the binding of NAD+ to the free enzyme) at both pH 7.0 
and 9.5 with different alcohols. 
 With the SlADHT114V mutant a primary kinetic isotope effect of 3.5 on φ0D / φ0H 
for [2H6]ethanol and ethanol was obtained. This is of the same magnitude as previously 
obtained for the SlADHwt enzyme and the Drosophila melanogaster alleloenzymes ADHS, 
ADHF and ADHUF [34, 36, 37, 258, 259]. This primary kinetic isotope effect indicates 
that the interconversion of the ternary complexes, i.e. the hydride transfer step (k) largely 
contributes to the rate limiting step in the oxidation of ethanol. The hydride transfer step 
has been reduced by approximately 4 times from 2.4s-1 in the SlADHwt enzyme to 0.6s-1 
in the SlADHT114V mutant. As with the wild-type enzyme, the rate of the hydride transfer 
step for ethanol with the mutant enzyme does not vary with pH.  
For the SlADHwt enzyme and the various DmADH alleloenzymes, the hydride 
transfer rate (k) for the secondary alcohol propan-2-ol was large compared to the 
E•NADH dissociation step (k´-1) [34, 35]. The reduction in hydride transfer rate 
introduced by a deuterium atom did not affect the maximum velocity. For the 
SlADHT114V mutant, the E•NADH dissociation rate (k´-1) was approximately the same as 
for the wild-type enzyme. The small primary isotope effect (φ0D / φ0H) of approximately 
1.6 obtained for [2H8]propan-2-ol in relation to propan-2-ol reveals that the rate limiting 
step with the isotope labelled alcohol has been changed to also include the hydride 
transfer step in addition to the E•NADH dissociation step. This also suggests that the rate 
of the hydride transfer step with propan-2-ol as a substrate has been reduced in the 
mutant compared to the wild-type enzyme. 
Previous studies with the SlADHwt and the DmADHS showed that the pH 
dependence of the alcohol binding to the binary E·NAD+ complex is derived exclusively 
from the on-velocity constant k2 [27, 34, 43]. The present work with the SlADHT114V 
mutant showed that the binding of ethanol to the binary DADH•NAD+ complex also is 
dependent on the release of a single proton from the binary complex and that the hydride 
transfer step is pH independent. The 0.8 unit increase in the pKa value for binding of 




supports the water relay hypothesis of a linked ionization of the Tyr151/Lys155 residues 
in the active site. The orientation of the Thr114 OH group is pH dependent. Hence, 
Thr114 can be considered as a switch that keeps the water chain active, i.e. acting as 
proton relay. The change of Thr114 to Val114 in the mutant results in a break of the 
hydrogen bond pattern in the water chain (Figure 13), and hence affects the proton 
release to the bulk water through the water chain. Thus our results suggest that the water 
channel in DADH acts as a proton relay in the binary DADH•NAD+ complex. However, 
our results reveal the hydride transfer step in the mutant enzyme is 4 times slower than in 
the wild-type enzyme. This suggests that the water chain also is important for the hydride 
transfer and that the proton transfer may affect the rate of the hydride transfer. 
 Molecular dynamic perspective of SlADHwt and SlADHT114V  5.1.2
From enzyme kinetic perspective, the studies in paper 1 verified the compulsory 
ordered mechanism of the SlADHT114V mutant and that the water relay system is 
important for optimal oxidation of alcohols by SlADHwt. However, in spite of differences 
in the enzyme kinetic constants, the X-ray crystal structure of the SlADHT114V mutant 
was very similar to the structure of SlADHwt.  The important question in paper 2 was 
therefore if the Thr114 to Val mutation not only could interfere with the proton relay 
system by removing a connecting link in the chain, but also induce differences in 
molecular dynamics between the SlADHwt and the SlADHT114V mutant. Molecular 
motions are important for proper enzyme function, and differences in the structural 
dynamics between the SlADHwt and the SlADHT114V mutant may also contribute to the 
differences in their kinetic coefficients. The molecular dynamics simulations in paper 2 
showed that there were differences in molecular dynamics in different regions of the 
enzymes between the SlADHwt and the SlADHT114V mutant.  
Measuring the substrate HAlc–OTyr151−  and HCAlc–C4NAD atomic distances during the 
MD showed that both 2-propanol and ethanol had more freedom for movements in the 
active site region of the SlADHwt than of the SlADHT114V mutant. This may in part 
explain the faster hydride transfer rate in the wild type enzyme compared to the mutant 
enzyme. In this region, the hydrogen bonding between Thr186 and nicotinamide ring of 
NAD+ is important for NAD+ binding. This hydrogen bond was stable in MD of the wild 




broken. However, during MD of the binary complexes, this hydrogen bond was more 
often seen in the mutant. This may indicate that substrate binding is favourable for 
forming the hydrogen bond between Thr186 and NAD+. The simulations indicated that 
the Thr114 to Val mutations alters the hydrogen bonding interactions between Thr186 
and the nicotinamide ring of NAD+ and thereby induces differences in the dynamical 
behaviour in the region of amino acids 175-210.  
Hydrophobic interaction and hydrogen bonds are the two main types of 
interaction between the adenine part of NAD+ and the hydrophobic pocket. The hydrogen 
bonding of adenine to both Asp63 and Val64 were generally reduced during MD with the 
mutant binary and ternary complexes compared with the corresponding wild type 
complexes. The adenine ring of NAD+ was then twisted closer to the water channel in the 
mutant than in the wild type.  
Another consequence of this change was the increased atomic distances between 
the side chain atoms of Ala92 and Val64 and between the side chain atoms of Ile106 and 
Val64 during the simulations of the ternary complexes of ethanol with the SlADHT114V 
mutant, while the atomic distance between Ile106 and Val64 decreased during MD of the 
ternary complex of 2-propanol with the SlADHT114V mutant. However, during all 
simulations with the ternary complexes of the SlADHwt, these atomic distances remained 
stable. These differences observed during the MD in the region of the adenine and 
nicotinamide moiety of NAD+ between the SlADHwt and the SlADHT114V mutant may 
affect the NAD+ binding at Rossman fold and contribute to the experimentally observed 
differences in NAD+ dissociation constant. The eight membered water channel may also 
be influenced by these dynamical changes since the water channels is situated close to the 
Rossman fold and the altered dynamics in the SlADHT114V mutant due to the mutation 
may therefore also affect the proton abstraction from the binary enzyme-NAD+ complex. 
Another hot spot is the region around amino acid 114. Several amino acids such 
as Gly110, Tyr62, Ser71, Pro67, Asn113 and Val66 are located around Thr144 (Val114). 
These amino acids may facilitate the proton transport from the NH3-group at the side 
chain of Lys155 into the bulk solution through the end part of water channel [260]. In the 
wild type enzyme, the MDs of the SlADHT114V indicated that several intramolecular 




interaction between Tyr62 and Ser71 seems very important since it is located in the end 
part of proton relay system close to the bulk solution (Figure 3).  This interaction was 
also reduced during MD with the SlADHT114V enzyme complexes and of the free 
SlADHT114V mutant enzyme compared with the corresponding simulations of the 
SlADHwt. All these differences in bonding interactions observed during MDs of the 
SlADHT114V mutant compared to the MDs of the SlADHwt in the region of water channel 
may contribute to a destabilizing of the end section of water chain in the mutant.  
 QM/MM studies of oxidation reaction mechanism of SlADH 5.1.3
In paper 1 we mentioned the relationship between water relay system and the two 
steps in alcohol oxidation reaction (hydride transfer and proton release). The 
experimental result indicated that the hydride transfer step in the oxidation of ethanol was 
approximately 4 times slower for the SlADHT114V mutant than for the SlADHwt. One can 
anticipate that disruption caused by the Thr114 to Val mutation on the water chain may 
affect the hydride transfer step under certain conditions. It is obvious that the differences 
in molecular motions between the SlADHT114V mutant and the SlADHwt found in paper 2 
may contribute to the difference in hydride transfer. However, other differences may also 
contribute that can depend on whether the proton transfer occurs prior to or at the same 
time as the hydride transfer and alternatively regulate the latter step. In paper 3 we were 
using QM/MM calculations to study the proton and hydride transfer steps during alcohol 
oxidation of both the SlADHwt and the SlADHT114V mutant enzymes.  Labeling of atoms 
mentioned in this section is given in Figure 2. 
  Previous studies have suggested that proton abstraction from the hydroxyl group 
of alcohol is drawn by a negatively charged Tyr151 that may be also be coupled to 
Lys155 [33, 46, 54, 230]. After docking and energy optimization of the ternary 
SlADHT114V mutant and SlADHwt complexes, the hydroxyl hydrogen atoms (HAlc) of both 
2-propanol and ethanol were located much closer to Tyr151 (approximately 1.6Å) than to 
Lys155 (approximately 4Å). This may indicate that the proton most likely is donated to 
Tyr151. 
During the QM/MM calculations of the hydride transfer step it seemed like the 
proton transfer step was closely linked to the hydride transfer step. When the CAlc–HCAlc 




(Figure 2) has decreased to 1.415 Å. we also got a sudden change in the CAlc–OAlc atom 
distance (1.43Å→1.32Å) and in the HAlc–OTyr151−   atomic distances (1.57Å→1.03Å) 
indicating that the proton transfer was initiated by the hydride transfer. Similar results 
were also obtained during the QM/MM relaxtion scans of the other complexes, the 
ternary complex of the SlADHwt with ethanol and the ternary complexes of the 
SlADHT114v mutant with 2-propanol and ethanol. This indicates three interesting 
phenomena: (1) Hydride transfer starts and at some point during the course, proton 
transfer starts and finish. (2) At the point when the proton transfer starts, a partly double 
bond character has been induced into the CAlc–OAlc bond. (3) The hydride transfer 
continues until reaching its finishing point accompanied with the formation of a CAlc–OAlc 
double bond.   
Especially, forming the partly double bond character most likely affects the pKa 
value of the alcohol OH group to a value lower than 7.1, i.e. the pKa value of the Tyr/Lys 
couple at the catalytic site of the wild type enzyme. This may explain why HAlc is 
transferred to OTyr151− .  
 However during QM/MM calculation of the scenario in which the proton transfer 
happens prior to hydride transfer step, the CAlc–OAlc atomic distance was only slightly 
decreased (from 1.44 Å to 1.4 Å) and a double bond character was not induced. 
Calculation of the activation energy for our favorable scenario showed that the SlADHwt 
had lower activation energy than the SlADHT114V mutant for 2-propanol, while the 
activation energy was highest for the SlADHwt with ethanol. That may indicate that the 
activation energy is not the reason for slower hydride transfer for the SlADHT114V mutant 











Despite their highly diverse substrate specificities, SDR family members show very 
similar folding pattern architectures, suggesting similarities in the catalytic mechanism 
and hence that SlADH can be used as a model enzyme for other SDR enzymes. The 
present study showed that the introduction of a Val instead of a Thr at position 114 in 
SlADH results in a break of the proton relay system. This break results in a slower kon 
velocity of NAD+ and a weaker binding of this coenzyme to the enzyme. Furthermore, it 
results in a slower hydride transfer from alcohol to NAD+ and an increase the pKa value 
of the group in the binary enzyme•NAD+ complex that regulates the kon velocity of the 
alcohol and alcohol competitive inhibitors. Hence, an intact water chain in drosophilid 
ADHs is essential for optimal enzyme activity. Other factors may also contribute to these 
changes, such as an altered dynamical behavior due to the mutation and the broken water 
chain.  
During the alcohol oxidation, hydride transfer most likely start first and initiate the 
proton transfer by lowering the pKa of hydroxyl group on alcohol. When the proton 
transfer is finished, the hydride transfer continues until it is finished. However, it is also 
important to have in mind the QM/MM method used in the present study has limitations, 
and the calculated activation energies could not explain why the hydride transfer is 
slower in the SlADHT114V mutant than in the SlADHwt, but still gives complementary 
explanations to the reaction order of these two steps.   More experimental and theoretical 
studies are necessary in order to gain more insight into the proton relay mechanism and 
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